Salmeterol Inhalation Powder Administered as the Xinafoate Salt From Hard Polyethylene Capsules Via the HandiHaler® 2, and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT02238106 · COMPLETED
Trial details
- NCT number
- NCT02238106
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2006-02-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.